Ascendis Pharma AS Net Asset Quality Index
Ascendis Pharma AS net asset quality index. Ascendis Pharma AS (ASND) has a Net Asset Quality Index of 24.4% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $2.01 Billion minus total liabilities of $1.52 Billion yields net assets of $488.48 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Ascendis Pharma AS earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Ascendis Pharma AS (2011–2025)
Net asset quality index of Ascendis Pharma AS from 2011 to 2025. This chart shows how Ascendis Pharma AS's Net Asset Quality Index has evolved across 15 annual periods from 2011 to 2025. As of March 2026, the index stands at 24.4%, representing net assets of $488.48 Million against total assets of $2.01 Billion USD. See Ascendis Pharma AS (ASND) net assets for net asset value and shareholders' equity analysis.
Ascendis Pharma AS Net Asset Quality Index by Year (2011–2025)
Ascendis Pharma AS net asset quality index by year from 2011 to 2025. The table below presents the year-by-year Net Asset Quality Index for Ascendis Pharma AS from 2011 to 2025, covering 15 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Ascendis Pharma AS (ASND) total market value.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -12.5% | $-162.75 Million | $1.30 Billion | $1.46 Billion | ▼ -3.5 pp |
| 2024 | -9.0% | $-105.71 Million | $1.18 Billion | $1.29 Billion | ▲ +8.7 pp |
| 2023 | -17.6% | $-145.70 Million | $825.59 Million | $971.28 Million | ▼ -41.8 pp |
| 2022 | 24.2% | $263.35 Million | $1.09 Billion | $826.39 Million | ▼ -57.3 pp |
| 2021 | 81.4% | $883.63 Million | $1.08 Billion | $201.29 Million | ▼ -4.2 pp |
| 2020 | 85.6% | $838.71 Million | $979.79 Million | $141.08 Million | ▼ -2.6 pp |
| 2019 | 88.2% | $597.11 Million | $676.73 Million | $79.62 Million | ▲ +0.4 pp |
| 2018 | 87.8% | $280.05 Million | $318.97 Million | $38.92 Million | ▼ -0.9 pp |
| 2017 | 88.7% | $187.21 Million | $210.98 Million | $23.77 Million | ▼ -4.2 pp |
| 2016 | 92.9% | $176.61 Million | $190.07 Million | $13.46 Million | ▲ +1.6 pp |
| 2015 | 91.3% | $120.33 Million | $131.77 Million | $11.45 Million | ▲ +13.2 pp |
| 2014 | 78.1% | $45.81 Million | $58.67 Million | $12.86 Million | ▲ +54.5 pp |
| 2013 | 23.6% | $6.30 Million | $26.70 Million | $20.40 Million | ▲ +17.5 pp |
| 2012 | 6.1% | $1.56 Million | $25.41 Million | $23.85 Million | ▲ +5.1 pp |
| 2011 | 1.0% | $233.00K | $22.82 Million | $22.59 Million | — |